Novavax (NVAX) Misses Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.29 +3.22%
EPS Growth %: -164.5%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -164.5%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.33 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
